ConductScience.org, home

Paper36980678

NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer.

Curio S and 8 others. Cancers (Basel), 2023. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer. Papers, record 36980678. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980678

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
NKG2D Fine-Tunes the Local Inflammatory Response in Colorectal Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.66
iCite
Revised in PubMed
2026-05-26
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Curio SSophie
2Lin WWanzun
3Bromley CChristianhttps://orcid.org/0000-0001-6203-6891
4McGovern JJenny
5Triulzi CChiara
6Jonsson GGustav
7Ghislat GGhita
8Zelenay SSantiago
9Guerra NNadia

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Wellcome TrustUnited KingdomPubMed
22255Cancer Research UKUnited KingdomPubMed
203948/Z/16AWellcome TrustUnited KingdomPubMed
RCDF088381/Z/09/ZWellcome TrustUnited KingdomPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128366766Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers.Mol Ther2017https://conductscience.org/library/papers/28366766PubMed
233613769CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety.J Cancer2021https://conductscience.org/library/papers/33613769PubMed
316184547Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.Int J Cancer2006https://conductscience.org/library/papers/16184547PubMed
434719204Expression of MHC class I polypeptide-related sequence A (MICA) in colorectal cancer.Front Biosci (Landmark Ed)2021https://conductscience.org/library/papers/34719204PubMed
57576992ApcMin: a mouse model for intestinal and mammary tumorigenesis.Eur J Cancer1995https://conductscience.org/library/papers/7576992PubMed
633868281Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer.Front Immunol2021https://conductscience.org/library/papers/33868281PubMed
729786848Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.Cancer2018https://conductscience.org/library/papers/29786848PubMed
827912061Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade.Cell2016https://conductscience.org/library/papers/27912061PubMed
935191428Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell Therapy.J Immunother2022https://conductscience.org/library/papers/35191428PubMed
1036764323
CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial.
Lancet Haematol2023https://conductscience.org/library/papers/36764323PubMed
1128344808Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer.J Immunother Cancer2017https://conductscience.org/library/papers/28344808PubMed
1232853984CAR-NK cells: A promising cellular immunotherapy for cancer.EBioMedicine2020https://conductscience.org/library/papers/32853984PubMed
1330984204NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment.Front Immunol2019https://conductscience.org/library/papers/30984204PubMed
1426041808NKG2D Receptor and Its Ligands in Host Defense.Cancer Immunol Res2015https://conductscience.org/library/papers/26041808PubMed
1533142138Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome.Mol Immunol2020https://conductscience.org/library/papers/33142138PubMed
1614762782Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.Gastroenterology2004https://conductscience.org/library/papers/14762782PubMed
1717052257Multistep carcinogenesis of the colon in Apc(Min/+) mouse.Cancer Sci2007https://conductscience.org/library/papers/17052257PubMed
1826442803Strain-dependent Lethal Toxicity in NKG2D Ligand-targeted CAR T-cell Therapy.Mol Ther2015https://conductscience.org/library/papers/26442803PubMed
1927849169Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell-Treated Mice.J Immunol2016https://conductscience.org/library/papers/27849169PubMed
2026457759The consensus molecular subtypes of colorectal cancer.Nat Med2015https://conductscience.org/library/papers/26457759PubMed

See all 44 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
40868987Molecular Mechanisms of Phytochemicals from Chaga Mushroom (Inonotus obliquus) Against Colorectal Cancer: Insights from Network Pharmacology, Molecular Docking, and Bioinformatics.Int J Mol Sci2025https://conductscience.org/library/papers/40868987PubMed
40849493Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40849493PubMed
40534857T cell-mediated immune surveillance conferred by latent Epstein-Barr virus genes suppresses a broad spectrum of tumor formation through NKG2D-NKG2DL interactions.Front Immunol2025https://conductscience.org/library/papers/40534857PubMed
39817244Cell type-specific upregulation of NKG2D ligand MICA in response to APTO253.Ann Transl Med2024https://conductscience.org/library/papers/39817244PubMed
38948479Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC.Front Surg2024https://conductscience.org/library/papers/38948479PubMed
37626965The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer.Biology (Basel)2023https://conductscience.org/library/papers/37626965PubMed

Download CSV of cited by

Genes26

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
CD27939PubTator's text mininghttps://conductscience.org/library/genes/939NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
GZMB3002PubTator's text mininghttps://conductscience.org/library/genes/3002NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605NCBI Gene
ITGAE3682PubTator's text mininghttps://conductscience.org/library/genes/3682NCBI Gene
KLRD13824PubTator's text mininghttps://conductscience.org/library/genes/3824NCBI Gene
KLRK122914PubTator's text mininghttps://conductscience.org/library/genes/22914NCBI Gene
LAG33902PubTator's text mininghttps://conductscience.org/library/genes/3902NCBI Gene
MICA100507436PubTator's text mininghttps://conductscience.org/library/genes/100507436NCBI Gene
MICB4277PubTator's text mininghttps://conductscience.org/library/genes/4277NCBI Gene
NR1I39970PubTator's text mininghttps://conductscience.org/library/genes/9970NCBI Gene
PDCD15133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PDCD1LG280380PubTator's text mininghttps://conductscience.org/library/genes/80380NCBI Gene
RAET1L154064PubTator's text mininghttps://conductscience.org/library/genes/154064NCBI Gene

See all 26 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980678

GET https://conductscience.org/api/papers/v1/36980678/references?page=2